Price: $399.99 for 30 months (Base Package)
Access: 30 months of continuous online access
Deliverables: 12.0 AAPA Category 1 Self-Assessment CME Credits (Pharmacology) or 100 AAPA Category 1 CME Credits (PANRE Review), Question Banks with Detailed Explanations
Physician assistants (PAs) must maintain NCCPA certification by earning 100 CME credits every two years. At least 50 of these must be Category 1 credits. While many general courses satisfy the basic credit requirement, selecting a high-yield pharmacology course requires evaluating accreditation, efficiency, and the utility of your CME budget.
Choosing an online pharmacology CME involves more than just clicking through slides. You must ensure the course meets specific state licensure requirements for prescriptive authority and provides enough clinical depth to assist in daily practice. This guide compares essential factors for selecting pharmacology CME and highlights how CME Review Courses streamlines this process.
Accreditation: AAPA Category 1 vs. Category 2
The most critical factor in your selection is the type of credit awarded. AAPA Category 1 credit is formally planned and accredited by the AAPA. Category 2 credit is self-reported and less formal. For most PAs, Category 1 is the priority to meet the 50-credit minimum for the NCCPA.
Our Pharmacology Review Course CME Package provides 12.0 hours of AAPA Category 1 Self-Assessment CME credit. Self-assessment credit is highly valuable because the NCCPA applies a 50% weighting bonus. This means your 12.0 credits effectively count as 18 credits toward your 100-hour requirement.
In contrast, general review courses or free pharmacology webinars often offer only Category 2 or standard Category 1 credit without the self-assessment bonus. If your goal is efficiency, self-assessment packages are superior.
Meeting State Prescriptive Authority Requirements
Many states, such as Ohio, require a specific number of pharmacology hours (often 12) related to medications for license renewal and prescriptive authority. When comparing providers, verify that the curriculum specifically mentions "pharmacology" in the accreditation statement.
The Pharmacology Review Course at CME Review Courses is designed specifically to fulfill these 12-hour requirements. It covers clinical therapeutics and basic science principles across multiple specialties, including Internal Medicine, Family Medicine, and Emergency Medicine.
Maximizing Your CME Budget: The Gift Card Add-On
Most employers provide a dedicated CME allowance. Often, this money is "use it or lose it." Choosing a provider that allows you to maximize the value of these funds is a pragmatic financial decision.
CME Review Courses offers a unique structure where you can add an Amazon or Apple Gift Card (ranging from $100 to $1500) to your CME purchase. This allows you to further your education by purchasing medical textbooks, clinical equipment, or digital tools via Amazon or Apple. This turns your required certification maintenance into a broader investment in your professional toolkit.
Content Quality and Clinical Utility
A high-quality pharmacology course should do more than help you log hours; it should prepare you for the NCCPA exams (PANCE/PANRE) and clinical decision-making.
Our pharmacology content was written by PAs for PAs. It avoids the fluff often found in physician-led courses that may focus on research data rather than clinical application. The Pharmacology Review Course includes a 120-question bank with detailed explanations. For those seeking a more comprehensive review, the PANRE Review Course provides 100 hours of AAPA Category 1 CME credit, covering the full spectrum of the NCCPA blueprint.
Comparison Table: Online Pharmacology CME Features
| Feature | CME Review Courses (Pharmacology) | Generic Online Webinars | Large Conference Recordings |
|---|---|---|---|
| Credit Type | AAPA Category 1 Self-Assessment | AAPA Category 1 or 2 | AAPA Category 1 |
| NCCPA Bonus | Yes (50% Weighting) | No | No |
| Gift Card Add-on | Yes ($100 – $1500) | No | No |
| Access Duration | 30 Months | Varies (often 12 months) | Varies |
| Practice Questions | 120 Questions with Rationale | Minimal to None | None |
| State Compliance | Designed for 12-hr mandates | Unreliable | Varies |
Clinical Vignettes and Practice Questions
Testing your knowledge is the most effective way to ensure retention of pharmacologic principles. Below are practice questions typical of the content found in our pharmacology and PANRE review materials.
Clinical Vignette 1
Your patient is a 64-year-old male with a history of hypertension and chronic kidney disease (CKD) Stage 3. He presents for a follow-up. His current medications include lisinopril 20 mg daily. His blood pressure is 152/94 mmHg. Laboratory results show a serum potassium of 5.1 mEq/L and a serum creatinine of 1.9 mg/dL (baseline). You decide to add a diuretic.
Which of the following is the most appropriate next step in pharmacologic management?
A. Start Hydrochlorothiazide (HCTZ) 12.5 mg daily
B. Start Chlorthalidone 25 mg daily
C. Start Furosemide 20 mg daily
D. Start Spironolactone 25 mg daily
Explanation:
The correct answer is C. Start Furosemide 20 mg daily. Thiazide diuretics, such as HCTZ and chlorthalidone, lose their efficacy once the GFR drops below 30 mL/min (CKD Stage 4), and their effectiveness significantly diminishes even in Stage 3. Loop diuretics like furosemide are preferred in patients with advanced CKD or significant fluid overload who require diuresis.
- Choice A and B are incorrect because thiazides are less effective in patients with reduced GFR and elevated creatinine levels.
- Choice D is incorrect because spironolactone is a potassium-sparing diuretic. Given the patient's current potassium level of 5.1 mEq/L and concurrent use of an ACE inhibitor (lisinopril), spironolactone poses a high risk for life-threatening hyperkalemia.
Clinical Vignette 2
Your patient is a 28-year-old female who presents with a 3-day history of dysuria, urgency, and suprapubic pain. She has no fever, chills, or flank pain. She has no known drug allergies and is not pregnant. A urine dipstick is positive for nitrites and leukocyte esterase.
Which of the following is the most appropriate first-line antibiotic for this patient?
A. Ciprofloxacin 500 mg BID for 3 days
B. Nitrofurantoin 100 mg BID for 5 days
C. Cephalexin 500 mg QID for 7 days
D. Doxycycline 100 mg BID for 7 days
Explanation:
The correct answer is B. Nitrofurantoin 100 mg BID for 5 days. According to current IDSA guidelines for uncomplicated cystitis, nitrofurantoin (Macrobid), Trimethoprim-sulfamethoxazole (if local resistance is <20%), and fosfomycin are considered first-line agents. Nitrofurantoin is highly effective against common uropathogens like E. coli.
- Choice A is incorrect as fluoroquinolones (ciprofloxacin) are now reserved for more complex infections or when first-line agents cannot be used, due to the risk of significant side effects (tendon rupture, aortic dissection) and the desire to limit resistance.
- Choice C is an alternative but is generally considered second-line for uncomplicated cystitis due to lower efficacy compared to first-line agents.
- Choice D is used for urethritis (e.g., Chlamydia) but is not first-line for bacterial cystitis.
Clinical Vignette 3
Your patient is a 55-year-old male with a history of Type 2 Diabetes Mellitus and Heart Failure with reduced Ejection Fraction (HFrEF). His current A1c is 7.8% despite metformin 1000 mg BID. You want to add a second agent that provides both glycemic control and cardiovascular benefit.
Which medication class is most appropriate to add?
A. Glipizide (Sulfonylurea)
B. Pioglitazone (Thiazolidinedione)
C. Empagliflozin (SGLT2 inhibitor)
D. Sitagliptin (DPP-4 inhibitor)
Explanation:
The correct answer is C. Empagliflozin (SGLT2 inhibitor). SGLT2 inhibitors like empagliflozin and dapagliflozin have demonstrated significant mortality benefits in patients with HFrEF and are recommended for both glycemic control and heart failure management regardless of diabetic status.
- Choice A is a sulfonylurea which carries a risk of hypoglycemia and does not provide cardiovascular protection.
- Choice B is contraindicated in patients with symptomatic heart failure as it can cause fluid retention and exacerbate HFrEF.
- Choice D is weight-neutral and generally safe, but saxagliptin (another DPP-4 inhibitor) has been linked to increased heart failure hospitalizations, and sitagliptin does not offer the same robust CV benefits as SGLT2 inhibitors.
Why Choose CME Review Courses?
When you buy our PANRE Review Course, you receive 100 hours of AAPA Category 1 CME credit. This is the most efficient way to satisfy your entire two-year requirement in one package. If you specifically need pharmacology hours, our dedicated Pharmacology Review Course provides the 12.0 self-assessment credits you need for state compliance and prescriptive authority.
All our courses are accessible for 30 months, allowing you to reference the material long after you have earned your credits. This is particularly useful for PAs working in Family Medicine or Internal Medicine who encounter complex polypharmacy daily.
Final Considerations for PAs
- Check Expiration Dates: Ensure the course you choose is valid through your next logging cycle.
- Verify Self-Assessment Status: Always prioritize self-assessment for the 50% NCCPA bonus.
- Utilize CME Allowances: Use the gift card add-on options to purchase medical gear or books to further your clinical education.
- Specialty Focus: Ensure the pharmacology content covers the specific organ systems relevant to your practice, such as Cardiology, Neurology, or Psychiatry.
Our curriculum is built to provide an authoritative yet helpful educational experience. Whether you are a PA, NP, or a physician looking for high-quality Category 2 CME, our packages provide the clinical depth and logistical convenience required in modern medicine.
Ready to secure your credits and maximize your CME budget? Browse our CME packages with Gift Card add-ons here.